Literature DB >> 1323330

Orthotopic heart transplantation: an efficient treatment in a young boy with doxorubicin-induced cardiomyopathy.

A Lüthy1, M Furrer, M Waser, M Maggiorini, H J Pluess, F Real, B Weiss, A Gallino, M Turina.   

Abstract

We present the case of a boy who underwent orthotopic heart transplantation at the age of 14 years because of doxorubicin-induced cardiomyopathy 9 years after treatment of a Wilms tumor of the left kidney. Three years after heart transplantation the patient enjoys a normal daily life. Invasive studies show normal cardiac hemodynamic results and in spite of previous nephrectomy and long-term cyclosporine treatment, renal function is only slightly impaired. So far no secondary neoplasia has occurred under chronic immunosuppression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1323330

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  4 in total

1.  Anthracycline-induced cardiomyopathy.

Authors:  N G Fisher; A J Marshall
Journal:  Postgrad Med J       Date:  1999-05       Impact factor: 2.401

Review 2.  Drug-induced cardiovascular disorders.

Authors:  C Aengus Murphy; Henry J Dargie
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  Aggressive management of doxorubicin-induced cardiomyopathy associated with 'low' doses of doxorubicin.

Authors:  S Sriskandan; M E O'Brien; I E Smith; P Collins; M E Gore
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

Review 4.  Orthotopic Heart Transplantation and Mechanical Circulatory Support in Cancer Survivors: Challenges and Outcomes.

Authors:  Nina Ghosh; John Hilton
Journal:  J Oncol       Date:  2015-08-03       Impact factor: 4.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.